Who owns the HEPTARES trademark?

The HEPTARES trademark is owned by Nxera Pharma Co., Ltd.

What is the serial number for HEPTARES?

The USPTO serial number for HEPTARES is 79040354.

What is the registration number for HEPTARES?

HEPTARES is registered under USPTO registration number 3527699.

HEP

USPTO Trademark Record

REGISTERED

HEPTARES

Q: What class is the HEPTARES trademark registered in?

The HEPTARES trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79040354·Reg 3527699·Filed Jun 13, 2007

Owner Nxera Pharma Co., Ltd

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

HEPTARES (Serial No. 79040354), Registration No. 3527699, is a registered US trademark filed on Jun 13, 2007 by Nxera Pharma Co., Ltd. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: November 06, 2028

Mark Intelligence

HEPTARES (Reg. #3527699) is a registered US trademark that has been protecting its owner, Nxera Pharma Co., Ltd, since 2007. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 13, 2007

SERIAL

79040354

REG#

3527699

REGISTERED

Nov 04, 2008

Owner

Applicant

Nxera Pharma Co., Ltd

Entity

Corporation (Foreign)

Address

9-7-2 Akasaka Minato-ku, Tokyo 107-0052

Country

Attorney

Law firm

MARK B. HARRISON VENABLE LLP

Docket

60895-376761

Address

P.O. Box 34385, WASHINGTON, DC 20043-9998, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 13, 2007

Serial Number79040354

Registration No.3527699

Registration DateNov 04, 2008

Status DateNov 29, 2018

Published for OppositionAug 19, 2008

Next RenewalNovember 06, 2028

Mark TypeStandard characters

Attorney Docket60895-376761

Status DescriptionLive and registered, Section 71 accepted

Filing Signals

FILED

2007

YEARS AGO

19y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

63 events

NEW REPRESENTATIVE AT IB RECEIVED

Feb 19, 2026

NEW REPRESENTATIVE AT IB RECEIVED

Feb 19, 2026

NEW REPRESENTATIVE AT IB RECEIVED

Feb 19, 2026

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jun 14, 2024

CHANGE OF NAME/ADDRESS REC'D FROM IB

NEW REPRESENTATIVE AT IB RECEIVED

Nov 04, 2022

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF OWNER RECEIVED FROM IB

Nov 08, 2019

CHANGE OF OWNER RECEIVED FROM IB

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

Aug 21, 2019

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Jul 29, 2019

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 29, 2018

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED-SEC.71 ACCEPTED

Nov 29, 2018

REGISTERED-SEC.71 ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Nov 29, 2018

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

TEAS SECTION 71 RECEIVED

Nov 02, 2018

TEAS SECTION 71 RECEIVED

INTERNATIONAL REGISTRATION RENEWED

Jun 29, 2017

INTERNATIONAL REGISTRATION RENEWED

NEW REPRESENTATIVE AT IB RECEIVED

Jun 23, 2017

NEW REPRESENTATIVE AT IB RECEIVED

PARTIAL INVALIDATION PROCESSED BY THE IB

Mar 24, 2017

PARTIAL INVALIDATION PROCESSED BY THE IB

INVALIDATION PROCESSED

Mar 16, 2016

INVALIDATION PROCESSED

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Mar 16, 2016

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Jan 15, 2016

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

May 15, 2015

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - PARTIAL SEC 71 ACCEPTED

May 15, 2015

REGISTERED - PARTIAL SEC 71 ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED

May 15, 2015

NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED

PAPER RECEIVED

Apr 28, 2015

PAPER RECEIVED

REGISTERED-SEC.71 FILED

Apr 28, 2015

REGISTERED-SEC.71 FILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Jan 06, 2013

FINAL DECISION TRANSACTION PROCESSED BY IB

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jan 28, 2010

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DISPOSITION PROCESSED

Feb 13, 2009

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Feb 13, 2009

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 04, 2009

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Nov 04, 2008

REGISTERED-PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Oct 20, 2008

ASSIGNED TO EXAMINER

PUBLISHED FOR OPPOSITION

Aug 19, 2008

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Jul 30, 2008

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jul 11, 2008

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINERS AMENDMENT -WRITTEN

Jul 10, 2008

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 10, 2008

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 10, 2008

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 10, 2008

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 10, 2008

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Jul 10, 2008

ASSIGNED TO LIE

PRIORITY ACTION WRITTEN

Feb 25, 2008

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Feb 25, 2008

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Feb 25, 2008

NOTIFICATION OF PRIORITY ACTION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Feb 04, 2008

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 04, 2008

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 04, 2008

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 04, 2008

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 30, 2008

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 30, 2008

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 30, 2008

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 30, 2008

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 30, 2008

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 30, 2008

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

REFUSAL PROCESSED BY IB

Oct 26, 2007

REFUSAL PROCESSED BY IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 21, 2007

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

REFUSAL PROCESSED BY MPU

Sep 21, 2007

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 21, 2007

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 20, 2007

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

Sep 20, 2007

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 20, 2007

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 19, 2007

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Sep 19, 2007

NON-FINAL ACTION WRITTEN

NEW APPLICATION ENTERED

Aug 10, 2007

NEW APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 09, 2007

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

HEP

HEPTARES

86577541

NXERA PHARMA CO., LTD

REGISTERED

SOS

SOSEI HEPTARES

79288175

Nxera Pharma Co., Ltd

REGISTERED

HEPTARES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Nxera Pharma Co., Ltd

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company